bioRxivMicrobiologyPreprint
Extensive re-modelling of the cell wall during the development of Staphylococcus aureus bacteraemia
E. J. A. Douglas, N. Palk, T. Brignoli, D. Altwiley, M. Boura, M. Laabei, M. Recker, G. C. Cheung, R. Liu, R. C. Hseih, M. Otto, E. O'Brien, R. M. McLoughlin, R. C. Massey
Abstract
Introductory Paragraph / AbstractThe bloodstream represents a hostile environment that bacteria must overcome to cause bacteraemia. To understand how the major human pathogen Staphylococcus aureus manages this we have utilised a functional genomics approach to identify a number of new loci that affect the ability of the bacteria to survive exposure to serum, the critical first step in the development of bacteraemia. The expression of one of these genes, tcaA, was found to be induced upon exposure to serum, and we show that it is involved in the elaboration of a critical virulence factor, the wall teichoic acids (WTA), within the cell envelope. The activity of the TcaA protein alters the sensitivity of the bacteria to cell wall attacking agents, including antimicrobial peptides, human defence fatty acids, and several antibiotics. This protein also affects the autolytic activity and lysostaphin sensitivity of the bacteria, suggesting that in addition to changing WTA abundance in the cell envelope, it also plays a role in peptidoglycan crosslinking. With TcaA rendering the bacteria more susceptible to serum killing, while simultaneously increasing the abundance of WTA in the cell envelope, it was unclear what effect this protein may have during infection. To explore this, we examined human data and performed murine experimental infections. Collectively, our data suggests that whilst mutations in tcaA are selected for during bacteraemia, this protein positively contributes to the virulence of S. aureus through its involvement in altering the cell wall architecture of the bacteria, a process that appears to play a key role in the development of bacteraemia.
- organism: human
- organism: mouse
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Self-sensitisation of Staphylococcus aureus to the antimicrobial factors found in human blood.
E. Douglas, T. Brignoli, … R. C. Massey·bioRxiv·Jul 19, 2021
- Wall teichoic acids facilitate the release of toxins from the surface of Staphylococcus aureus.
T. Brignoli, E. J. Douglas, … R. C. Massey·bioRxiv·Jan 31, 2022
- The capsular polysaccharide obstructs wall teichoic acid functions in Staphylococcus aureus
E. Lehmann, R. van Dalen, … C. Wolz·bioRxiv·Jul 26, 2023
- PBP4 is required for serum-induced cell wall thickening and antibiotic tolerance in Staphylococcus aureus
Elizabeth V. K. Ledger, Ruth C. Massey·Antimicrobial Agents and ChemotherapyPeer-reviewed·Oct 21, 2024
- The two-component system ArlRS is essential for wall teichoic acid glycoswitching in Staphylococcus aureus
Marieke M. Kuijk, Emma Tusveld, … Nina M. van Sorge·mBioPeer-reviewed·Nov 29, 2024
- Inactivation of the monofunctional peptidoglycan glycosyltransferase SgtB allows Staphylococcus aureus to survive in the absence of lipoteichoic acid
E. Karinou, C. F. Schuster, … A. Grundling·bioRxiv·Sep 17, 2018